Natural Killer Cell KIR and HLA Genotypes May Predict Response to Antibody Therapy in Follicular Lymphoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Monoclonal antibodies; Rituximab
- Indications Follicular lymphoma
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
Most Recent Events
- 27 Jun 2017 Biomarkers information updated
- 25 Feb 2010 Actual initiation date (Feb 2010) added as reported by ClinicalTrials.gov.
- 25 Feb 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.